Turning Around a Troubled Study: A Rescue Project Success Story

Turning Around a Troubled Study: A Rescue Project Success Story

When you have a program that has stalled or gone off schedule, it is vital to team up with a CRO laboratory that is capable of handling quick turnarounds and rescue projects. We look at an example of how BioAgilytix sprung to action to transform a troubled study.

CLIA Requirements for Gene and Cell Therapy Programs

It’s a common misconception that all aspects of cell & gene therapy research and development are excluded from CLIA oversight. We take a closer look at testing and when CLIA requirements apply.

Vector Innovation to Improve Gene Therapy Safety: A Credit to Scientific Tenacity

BioAgilytix Gene editing - genes therapy concept with nurse & DNA lab technician medical laboratory

A new clinical trial by St. Jude Children’s Research Hospital for the treatment of SCID-X1 highlights a major advancement in gene therapy safety over recent years, in this case spurred by scientists who were courageous enough to push forward the development of safer vectors to overcome serious adverse events (SAEs) that were resulting from the previous generation of gene therapies developed for SCID-X1.